Trial intelligence / Profile preview

COVER DFUs II: SkinTE for Wagner 1 Diabetic Foot Ulcers

NCT06140303Phase 3Completed

Sponsor
PolarityBio
Start
Feb 2024
Primary completion
Jan 2026
Modality
Implantable Devices, Implantable Hydrogels, Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of SkinTE in diabetic foot ulcer (DFU), sponsored by PolarityBio. Started Feb 2024; status: completed.

02

Drugs

SkinTE
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT06140303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06140303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call